Improve your screening know-how with TTP LabTech at Screening Europe 2010
News Jan 28, 2010
On 11th February, TTP LabTech will be offering a free workshop entitled “The Identification of novel cancer targets using a rapid, high-content, genome wide RNAi screen”. Based on the Acumen platform, this workshop will describe how information identifying high quality hits can be accessed quickly and easily either by in-house data generation or via an outsourced service.
In addition, Gaetan Touyer, Head of Screening Group, Vitry Research Center at Sanofi Aventis will present a study of five screening assays, including cell-based protein-protein interaction, homogeneous cell receptor ligand binding and cell cycle analysis at 11.45am on the 12th February. The talk explores his experiences of integrating the Acumen eX3 microplate cytometer into an HTS platform to achieve a screening throughput of tens of thousands of wells per day using a complex yet controlled process with multiple experimental steps.
Visitors to the TTP LabTech stand #12, will also be able to find out more about the new high content screening service now on offer. Based on the industry-proven Acumen platform, this service offers a highly flexible approach to cell-based screening, providing high-throughput, content-rich and highly multiplexed data for applications such as target identification, primary screening and preclinical toxicology.
Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Their research revealed a promising strategy to develop a suitable agent. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.READ MORE
In a strategic search, scientists created and screened a library of 45,000 new compounds containing chemical elements of widely used immune system suppressants, and say they found one that may prevent reperfusion injury, a tissue-damaging and common complication of surgery, heart attack and stroke.READ MORE